Aljazira remains ‘neutral’ on Mouwasat; sets TP at SAR 143.4

24/06/2015 Argaam

Aljazira Capital, the investment arm of Bank Aljazira, maintained its neutral recommendation for Mouwasat Medical Services Company, and set a target price of SAR 143.4 per share for the stock.

 

Mouwasat’s profit is expected to grow 17.4 percent to SAR 281.8 million this year, thanks to the opening of its new Riyadh-based hospital in first quarter, Aljazira added. 

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.